What You Need To Know About Investing in CVS Caremark, Walgreen Co., and Rite Aid Stock

Rising enrollment in health-care insurance plans and aging baby boomers offer opportunity for sales growth at drug delivery companies.

Sep 3, 2014 at 7:45AM

Some of the world's most successful businesses are those that consumers rely upon to deliver not only great products at great prices, but trustworthy advice, too.

In healthcare, pharmacies like CVS Caremark (NYSE:CVS), Walgreen Co. (NASDAQ:WBA), and Rite Aid (NYSE:RAD) are perfectly positioned to achieve these ends by offering consumers a convenient and credible source for filling prescriptions. Since the number of prescriptions filled is expected to grow significantly as the number of Americans age 65 years or older doubles, let's look at this industry and see whether these companies should be in Foolish portfolios.


Source: Walgreen.

What are pharmacies?
Pharmacies act as the go-between between drugmakers and patients and CVS Caremark, Walgreen, and Rite Aid are among the biggest pharmacy operators. These powerhouse retailers don't develop medicine themselves, but they do provide customers with a simple shopping experience that allows them to fill prescriptions quickly and cheaply.

While CVS, Walgreen, and Rite Aid pharmacies are common in every town and city block, other companies compete to fill prescriptions too. For example, hospitals are major healthcare providers and dispense prescriptions directly to their patients; pharmacy benefit managers like Express Scripts run insurer drug plans and offer mail order drug delivery; and large mass merchandise retailers such as Wal-Mart and Target, along with Kroger and other grocery chains, have also opened pharmacies within their stores too.

How do pharmacies work?
Historically, pharmacies were mostly independently owned and operated; however, rising real estate costs and salaries and stiff competition has shifted the market to favor large companies. As a result, thousands of Walgreen, CVS Caremark, and Rite Aid stores fill more than one-third of the nation's prescriptions. 

Pharmacies tend to make most of their money by filling prescriptions, but many also generate substantial revenue through selling general merchandise such as batteries and over-the-counter medicines

Although market share growth and a blurring of the lines between pharmacy benefit managers and pharmacies provides these companies with profit-friendly purchasing power, pharmacy operating margins remain in the mid-single digits.


Source: CVS Caremark

What's driving the pharmacy industry?
Doctor visits have the biggest impact on pharmacy demand and those visits are driven primarily by patient health, accessibility of care, and affordability of that care.

Since roughly 10,000 baby boomers are turning 65 every day through 2029, and demand for health care rises significantly as we age, prescription volume is expected to climb substantially over the coming decade. According to Rite Aid, the average person aged 65 to 74 years old fills nearly two times the number of prescriptions every year as those aged 45 years to 54 years old.

But it's not just ageing America that supports pharmacy sales. The Affordable Care Act is adding millions of previously uninsured patients to both private and public insurance plans and since these patients are visiting doctors more frequently, significantly more prescriptions are being written.

In order to boost market share, pharmacies are increasingly targeting older and newly insured patients by offering basic and chronic care treatment within in-store health care clinics. These clinics are oftentimes more convenient than primary-care practices and are cheaper than hospital ER and urgent care visits. As a result, these health care clinics are increasingly attractive to patients and the resulting patient volume growth is boosting pharmacy prescription demand and front-end sales. So far, CVS is the largest operator of these health care clinics with more than 800 locations, but Walgreen also operates hundreds of these clinics, and Rite Aid is starting to open them too.

While pharmacies are innovating to increase access and lower costs of care, they're also benefiting from the rising use of generic drugs. Pharmacies earn a higher margin on generics than they do on generic's branded counterparts; so with patents on billions of dollars' worth of branded drugs expiring every year, and generic drugs representing nearly 80% of all prescriptions filled, pharmacies should enjoy earnings tailwinds over the coming years.

Why invest in pharmacies?
Pharmacies are an important link in the healthcare chain. They fill prescriptions quickly and cheaply and are likely to see sales volume grow thanks to an older, longer-living population and reform-driven insurance enrollment. The trend toward low-cost generic drugs offers ongoing margin support; however, the industry continues to invest significantly into new services and programs, which reduces earnings. Having said that, investors willing to take the long view on pharmacies may find that they're rewarded as these companies expand to meet growing demand.

Leaked: This revolutionary blockbuster will make every pharmacy jealous
The best biotech investors consistently reap gigantic profits by recognizing true potential earlier and more accurately than anyone else. Let me cut right to the chase. There is a product in development that will revolutionize not just how we treat a common chronic illness, but potentially the entire health industry. Analysts are already licking their chops at the sales potential. In order to outsmart Wall Street and realize multi-bagger returns you will need The Motley Fool's new free report on the dream-team responsible for this game-changing blockbuster. CLICK HERE NOW.

Todd Campbell has no position in any stocks mentioned. Todd owns E.B. Capital Markets,LLC. E.B. Capital's clients may or may not have positions in the companies mentioned. Todd owns Gundalow Advisors, LLC. Gundalow's clients do not have positions in the companies mentioned. The Motley Fool recommends CVS Caremark and Express Scripts. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

1 Key Step to Get Rich

Our mission at The Motley Fool is to help the world invest better. Whether that’s helping people overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we can help.

Feb 1, 2016 at 4:54PM

To be perfectly clear, this is not a get-rich action that my Foolish colleagues and I came up with. But we wouldn't argue with the approach.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich" rated The Motley Fool as the #1 place online to get smarter about investing.

"The Motley Fool aims to build a strong investment community, which it does by providing a variety of resources: the website, books, a newspaper column, a radio [show], and [newsletters]," wrote (the clearly insightful and talented) money reporter Kathleen Elkins. "This site has something for every type of investor, from basic lessons for beginners to investing commentary on mutual funds, stock sectors, and value for the more advanced."

Our mission at The Motley Fool is to help the world invest better, so it's nice to receive that kind of recognition. It lets us know we're doing our job.

Whether that's helping the entirely uninitiated overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we want to provide our readers with a boost to the next step on their journey to financial independence.

Articles and beyond

As Business Insider wrote, there are a number of resources available from the Fool for investors of all levels and styles.

In addition to the dozens of free articles we publish every day on our website, I want to highlight two must-see spots in your tour of fool.com.

For the beginning investor

Investing can seem like a Big Deal to those who have yet to buy their first stock. Many investment professionals try to infuse the conversation with jargon in order to deter individual investors from tackling it on their own (and to justify their often sky-high fees).

But the individual investor can beat the market. The real secret to investing is that it doesn't take tons of money, endless hours, or super-secret formulas that only experts possess.

That's why we created a best-selling guide that walks investors-to-be through everything they need to know to get started. And because we're so dedicated to our mission, we've made that available for free.

If you're just starting out (or want to help out someone who is), go to www.fool.com/beginners, drop in your email address, and you'll be able to instantly access the quick-read guide ... for free.

For the listener

Whether it's on the stationary exercise bike or during my daily commute, I spend a lot of time going nowhere. But I've found a way to make that time benefit me.

The Motley Fool offers five podcasts that I refer to as "binge-worthy financial information."

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. It's also featured on several dozen radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable ... and I don't say that simply because the hosts all sit within a Nerf-gun shot of my desk. Rule Breaker Investing and Answers contain timeless advice, so you might want to go back to the beginning with those. The other three take their cues from the market, so you'll want to listen to the most recent first. All are available at www.fool.com/podcasts.

But wait, there's more

The book and the podcasts – both free ... both awesome – also come with an ongoing benefit. If you download the book, or if you enter your email address in the magical box at the podcasts page, you'll get ongoing market coverage sent straight to your inbox.

Investor Insights is valuable and enjoyable coverage of everything from macroeconomic events to investing strategies to our analyst's travels around the world to find the next big thing. Also free.

Get the book. Listen to a podcast. Sign up for Investor Insights. I'm not saying that any of those things will make you rich ... but Business Insider seems to think so.

Compare Brokers